Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lung Neoplasms × COVID-19 Vaccines × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

COVID-19 4 Neoplasms 2 Rheumatic Diseases 1 Papillomavirus Infections 1 Nervous System Diseases 1 Lung Neoplasms 1 Hematologic Diseases 1

Interventions

Carboplatin 152 Paclitaxel 111 Radiotherapy 110 Cisplatin 101 Docetaxel 85 Gemcitabine 76 Pemetrexed 72 Erlotinib Hydrochloride 70 Bevacizumab 45 Etoposide 38 pembrolizumab 31 Vinorelbine 30 Topotecan 28 Gefitinib 26 Irinotecan 25 Surveys and Questionnaires 23 Radiosurgery 18 Magnetic Resonance Spectroscopy 18 Drug Therapy 18 Nivolumab 17 Cetuximab 16 durvalumab 15 Cyclophosphamide 15 Surgical Procedures, Operative 14 Immunohistochemistry 14 Celecoxib 14 Gene Expression Profiling 13 Filgrastim 13 Early Intervention, Educational 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05009030 2022-07-29

VAC-CaP

Fundación GECP

COVID-19, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡